戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1098897作成日:2026年10月25日

Butyronitrile → (alphaS,betaR)-beta-{[1-(3-Pyridyl)-1H-indazole-5-yl]oxy}-alpha-methylbenzeneethanamine

https://huagongshe.com/reaction/1098897

反応式

関与物質

役割名称HCID仕込み量
反応物ButyronitrileHCID 8008—
反応物PhenylpropanolamineHCID 10297—
反応物Cesium carbonateHCID 10796—
反応物5-iodo-1-pyridin-3-yl-1H-indazoleHCID 59786571—
触媒Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)HCID 24350—
生成物(alphaS,betaR)-beta-{[1-(3-Pyridyl)-1H-indazole-5-yl]oxy}-alpha-methylbenzeneethanamineHCID 6681293027%

反応手順

(1R,2S)-Norephedrine (500 mg, 3.31 mmol), 5-iodo-1-(3-pyridyl)-1H-indazole (1.08 g, 33.37 mmol), cesiumcarbonate (2.15 g, 6.61 mmol), copper (I)-iodide (314.9 mg, 1.65 mmol) and butyronitrile (2 mL) are stirred in a glass pressure tube at 120° C. for 20 h. The reaction mixture is filtered via a glass microfibre filter, the solvent evaporated and the residue purified by chromatography (silicagel, eluents: dichloromethane/methanol). 307.8 mg (27%) of the title compound are obtained.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08143290B2
出典データセットuspto-grants-2012_03
ORD IDord-fc057815b231437ab2581cbf9d0d510a
出典メモuspto-grants-2012_03